Given a urinary estrone‑3‑glucuronide rise to 129.9 on day 8 after the luteinizing hormone peak followed by a drop to 40.2 on day 9, and 20 days of supplemented pregnanediol‑3‑glucuronide, is implantation and conception still possible?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Likelihood of Implantation with Declining E1G After Day 8 Post-LH Peak

Your E1G pattern—rising to 129.9 on day 8 then dropping sharply to 40.2 on day 9 post-LH peak—suggests that implantation and conception remain possible, though the sharp decline in estrogen after the mid-luteal rise is not the typical pattern seen in successful conception cycles.

Understanding Your Hormone Pattern

Your urinary hormone measurements show:

  • Day 7 post-LH peak: E1G 43.8
  • Day 8 post-LH peak: E1G 129.9 (approximately 3-fold increase)
  • Day 9 post-LH peak: E1G 40.2 (sharp drop to baseline)
  • PDG: Supplemented at 20 throughout

What These Values Mean

The E1G rise on day 8 is physiologically appropriate. Research demonstrates that urinary estrone-3-glucuronide typically shows a secondary rise during the mid-luteal phase (days 7-9 post-ovulation), reflecting increased estrogen production by the corpus luteum 1, 2. Your peak of 129.9 represents approximately a 3-fold increase from baseline, which falls within the expected 5-7 fold range from early follicular to luteal peak values 1.

However, the sharp decline to 40.2 on day 9 is concerning. In normal ovulatory cycles with adequate luteal function, E1G levels typically remain elevated throughout the mid-luteal phase rather than dropping precipitously after a single day 2, 3. This pattern may indicate:

  • Inadequate corpus luteum function despite progesterone supplementation
  • A cycle that may not result in pregnancy even if fertilization occurred
  • Possible luteal phase deficiency affecting endometrial receptivity

Implantation Timing and Window

Implantation typically occurs 6-12 days after ovulation, with peak implantation at 8-10 days post-ovulation 4. Since you are measuring at days 7-9 post-LH peak (which corresponds roughly to days 6-8 post-ovulation, as ovulation occurs approximately 24-30 hours after LH surge), you are within the critical implantation window 4, 5.

The egg remains viable for only 12-24 hours after ovulation 4, so if fertilization was going to occur, it would have happened by day 1-2 post-ovulation. The question now is whether the endometrial environment can support implantation.

Impact of Progesterone Supplementation

Your PDG supplementation at 20 is artificially maintaining progesterone levels 6, 2. While this supports the endometrial lining structurally, the sharp E1G decline suggests the corpus luteum itself may not be functioning optimally. Research shows that both estrogen and progesterone are required for successful implantation and early pregnancy maintenance 2, 3.

The concern is that supplemented progesterone alone may not compensate for inadequate estrogen production during the critical implantation window. Studies demonstrate that cycles with deficient luteal phases—characterized by inadequate hormone production—have lower implantation rates even when progesterone is supplemented 2.

Clinical Interpretation and Next Steps

Is Pregnancy Still Possible?

Yes, pregnancy remains possible but less likely than in cycles with sustained mid-luteal estrogen elevation. The brief E1G rise on day 8 indicates some corpus luteum activity, and if an embryo is present and healthy, it may still implant despite suboptimal hormonal support 2, 3.

What to Monitor

  • Continue progesterone supplementation as prescribed, since stopping now could further compromise any potential pregnancy 6
  • Wait until at least 14 days post-ovulation (approximately day 12-13 post-LH peak) before testing for pregnancy 7
  • If initial urine pregnancy test is negative at 14 days post-ovulation, repeat testing 2-4 weeks later to definitively exclude pregnancy, as 2-4% of viable pregnancies may still be negative at the typical testing timepoint 7
  • Consider serum beta-hCG testing if clinical suspicion remains high despite negative urine tests, as serum tests are more sensitive 7

Common Pitfalls to Avoid

Do not stop progesterone supplementation prematurely based on the E1G decline alone 6. If pregnancy has occurred, abrupt cessation could precipitate pregnancy loss.

Do not rely on a single negative urine pregnancy test to definitively exclude pregnancy 7. Dilute urine, test sensitivity variations, and delayed implantation can all produce false negatives in viable pregnancies.

Do not assume this pattern definitively rules out pregnancy 2, 3. While not optimal, individual variation in hormone patterns means some women may achieve pregnancy despite atypical mid-luteal hormone profiles.

Long-Term Considerations

If this cycle does not result in pregnancy, discuss comprehensive luteal phase evaluation with your fertility specialist 2. The pattern you describe—a brief mid-luteal E1G rise followed by rapid decline—may indicate corpus luteum insufficiency that requires different management strategies in future cycles, such as:

  • Ovarian stimulation protocols to improve follicle quality and subsequent corpus luteum function 8
  • Trigger timing optimization to ensure optimal follicle maturation before ovulation 9
  • Combined estrogen and progesterone supplementation rather than progesterone alone 2

References

Research

Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2015

Guideline

Timing of Ovulation and Fertility

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pregnancy Detection After IUI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

hCG Trigger Injections in Fertility Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

My fertile window opened today on cycle day 11 with estrone‑3‑glucuronide (E1G) 38.3 ng/mL and pregnanediol‑glucuronide (PdG) 6.5 µg/mL; when will the luteinizing hormone (LH) surge occur?
Based on my hormone trends (luteinizing hormone surge, estrone‑3‑glucuronide and pregnanediol‑glucuronide levels) and cramps on cycle day 15, did I ovulate, on which cycle day did ovulation occur, when should I start progesterone therapy for luteal phase insufficiency, and how long does the released oocyte remain viable for fertilization (e.g., through late cycle day 15 or day 16)?
Did I ovulate (based on LH peak 45 IU on cycle day 13, estrone‑glucuronide peak 288 ng/mL on day 13, and rising pregnanediol‑glucuronide) and if so when; when should I start progesterone supplementation for luteal‑phase insufficiency; and how long after ovulation remains the oocyte viable for fertilisation?
In a reproductive‑age woman tracking urinary estrone‑3‑glucuronide (E1G), does the level drop after embryo implantation or remain elevated/increase?
I am a woman of reproductive age using a urinary fertility monitor; based on my estrone‑3‑glucuronide (E1G), luteinising hormone (LH) and pregnanediol‑glucuronide (PDG) trends showing an LH surge peaking at 45 IU on cycle day 13 and still elevated on day 14, did I ovulate, and if so on which day? When should I begin progesterone supplementation for possible luteal phase insufficiency, and until when is the oocyte viable? Will intercourse on the evening of cycle day 15 still be within the fertile window?
What is the typical anemia type in adults with chronic kidney disease (CKD) and how should it be diagnosed and managed?
What is the recommended treatment for finger eczema?
How can milk aspiration be confirmed in a newborn infant?
Which biologic agents are used for moderate‑to‑severe inflammatory skin diseases in India, and what are their adult dosing schedules, required pre‑treatment screening, contraindications, and cost/access considerations?
In an adult male presenting with acute left testicular and spermatic cord pain, left lower‑quadrant abdominal discomfort, and dysuria, what is the differential diagnosis and immediate management?
What are the possible causes of excessive sweating in a young patient with hypertension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.